Market Overview

Jim Cramer Gives His Opinion On BioTelemetry And Enterprise Products Partners

Share:
Related BEAT
21 Stocks Moving In Thursday's Pre-Market Session
The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall
Related EPD
Earnings Scheduled For October 31, 2018
Earnings Scheduled For August 1, 2018
10 Dividend Achievers Alleged To Gain 27.5% To 62.92% Come December 2019 By Broker Targets (Seeking Alpha)

On CNBC's "Mad Money", Jim Cramer said he would hold a long position in BioTelemetry, Inc. (NASDAQ: BEAT).

Cramer also likes Enterprise Products Partners L.P. (NYSE: EPD), but he thinks the whole group is stuck because of the Energy Transfer Partners LP (NYSE: ETP). He added that Enterprise Products Partners is the real deal and he would stay long.

Posted-In: CNBC Mad Money Jim CramerMedia

 

Related Articles (BEAT + EPD)

View Comments and Join the Discussion!

GM, Tesla, Halliburton, L3 Technologies: 'Fast Money' Picks For December 13

Jim Cramer Shares His Thoughts On Johnson Controls And DR Horton